Başka bir renk deneyin:
Başka bir font büyüklüğü deneyin: 60% 70% 80% 90%


 


Sektörden Sayfası

2012 ACCSESS TO MEDICINE RAPORLARI

Ekteki dosyalarda sektör ile ilgili önemli bilgilere erişebilirsiniz
1. Access to medicine 2012 report
2. Research and development 2012
3. Public policy 2012
4. Patent problems
5. Pricing

REKABET KURUMU TÜRK İLAÇ SEKTÖRÜ RAPORU

"REKABET KURUMU"
"III. Denetim ve Uygulama Dairesi Başkanlığı" İLAÇ SEKTÖRÜ RAPORU

10 BÜYÜK FİRMANIN 2012 EKONOMİK ANALİZİ

Top Pharma Companies by 2012 Revenues

10 Secrets the Pharmaceutical Industry Does NOT Want You to Know 2nd Edition By Kay L.

Reçeteli İlaç Emniyeti: İlaç endüstrisinin bilmenizi istemediği 10 gizli sırrı

Prescription Drug Safety: 10 Secrets the Pharmaceutical Industry Does NOT Want You to Know
2nd Edition
By
Kay L.

What You Need to Know About the Fraudulent Nature of the Pharmaceutical Investment Business With Disease

The Laws of the Pharmaceutical Business with Disease

Some people may say that the pharmaceutical industry cannot be that bad. Unfortunately, it is. Fortunately, however, it is very easy for everyone to understand why this industry has such a detrimental effect on millions of human lives.

It is not about individual drugs or individual companies. It is about the principles – the laws – of the pharmaceutical ‘business with disease’. The most important of these laws can be summarized in the following way:

İLAÇ FİRMALARINA NE KADAR GÜVENİLİR? 2012 HASTA GRUPLARI ANKET SONUÇLARI

Son senelerde hemen bütün ülkelerde ilaç sanayiinin kurumsal kimliği gittikçe dibe vurmakta ve inanırlığını kaybetmekte. İlaç firmalarının ilaç emniyeti, fiyatlandırma ve şeffaflığına güven kaybolmakta.

AVRUPA KONSEYİ REÇETELİ İLAÇ SINIFLAMASI

RESOLUTION RESAP(2007)1
ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY
(superseding Resolution ResAP(2000)1 on the classification of medicines
which are obtainable only on medical prescription)

IMS SORUMLU İLAÇ KULLANIMI RAPORU (Advancing the responsible use of medicines)

This report was prepared for the Ministers Summit organized by the Dutch Ministry of Health, Welfare and Sport on the 3rd of October 2012 with the theme: The benefits of responsible use of medicines: Setting policies for better and cost-effective healthcare.

"Contents"
"I. The case for better use of medicines 11"
"II. Framing the approach and quantifying"
"the opportunity 17"
"III. Synthesised recommendations for"
"Ministers of Health: Outcomes and analysis 23"

TÜRKİYEDE İLAÇ SOYGUNUNA BİRKAÇ ÖRNEK

Ekteki dosyada son zamanlarda Türkiyede yapılan ilaç soygunları ve yolsuzluklarına bir-kaç örnek verilmiştir. Bu haberler 'DEVLET MALI DENİZ YEMEYEN DOMUZ' söyleminin acı bir doğrulaması. Soygunun birinci derecede sorumlularını hepimiz biliyoruz... OLAY ŞEYTAN ÜÇGENİ DEĞİL, ŞEYTAN BEŞGENİ.. İLAÇ SANAYİİ-DOKTOR-ECZACI-SGK-SAĞLIK BAKANLIĞI... Yemeyen domuzdur!!!!

ORANGE BOOK 2012 (FDA TARAFINDAN ONANMIŞ İLAÇLAR)

FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH APPROVED DRUG PRODUCTS
with Therapeutic Equivalence Evaluations

CONTENTS

PAGE

PREFACE TO THIRTY SECOND EDITION…iv 2
HOW TO USE THE DRUG PRODUCTS LISTS 2-1
2.1
Key Sections for Using the Drug Product Lists …………………….….………………
......
2-1
2.2
Drug Product Illustration ……………………………………………
..….…………….……..
2-3
2.3
Therapeutic Equivalence Evaluations Illustration ………………….….…………..………2-4 DRUG PRODUCT LISTS

İçeriği paylaş